Recall Radar
All recallsMedicine & devices

Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc…

Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

Class II Medicine & devices FDA September 2, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Hikma Pharmaceuticals USA INC. — Columbus, OH
Severity
Class II — moderate
Reported
September 2, 2026
Quantity
a) 25,970 bottles; b) 2,384 bottles
Recall number
D-0831-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide within the United States

Other medicine & devices recalls

See every current recall on the live dashboard →